🚨 WHO Issues Global Safety Alert on Semaglutide: Vision Loss Risk Identified
The World Health Organization (WHO) has issued an important global safety alert regarding the use of semaglutide-containing medicines, warning about a rare but serious side effect that could lead to irreversible vision loss. This update is highly relevant for healthcare professionals, endocrinologists, diabetologists, and all providers managing patients on semaglutide-based treatments such as Ozempic®, Rybelsus®, […]







